Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Nov;3(11):2473-6.
doi: 10.1002/j.1460-2075.1984.tb02158.x.

Deletion of the IgH enhancer does not reduce immunoglobulin heavy chain production of a hybridoma IgD class switch variant

Deletion of the IgH enhancer does not reduce immunoglobulin heavy chain production of a hybridoma IgD class switch variant

S Klein et al. EMBO J. 1984 Nov.

Abstract

Immunoglobulin (Ig) gene promotors are active only in cells of the B-lymphocyte lineage. Transfection experiments have shown that this is due in part to tissue specific 'activating' DNA sequences, so called enhancers. It is not entirely clear whether these sequences are necessary for initial activation or also for maintenance of transcription of a gene. We describe here the isolation and characterisation of a mouse hybridoma cell line that has deleted in vitro the 'activating' sequence from the active IgH locus, the only IgH locus it contains. Nevertheless, Ig heavy chain production of the variant cell is not impaired and remains comparable with that of other hybridoma cells. Therefore, a high rate of Ig heavy chain production in antibody-producing cells is either independent of any sequences enhancing transcription or else these can easily be replaced by other DNA sequences with a similar function that have been moved into the vicinity of the V region.

PubMed Disclaimer

References

    1. Cell. 1981 Dec;27(2 Pt 1):381-90 - PubMed
    1. Cell. 1981 Jun;24(3):625-37 - PubMed
    1. Immunol Rev. 1982;67:59-72 - PubMed
    1. Eur J Immunol. 1982 Nov;12(11):935-42 - PubMed
    1. J Immunol Methods. 1983 Feb 11;56(3):329-39 - PubMed

Publication types